NATCO Pharma Limited has announced the launch of Bosentan tablets for oral suspension (TFOS), 32 mg, in the United States.
Pharma compliance software is significant for Pharmaceutical regulations, and it set to become newer and more complex in 2025. Many companies are adopting advanced compliance software to help streamline compliance gained by multilayered requirements
Robocore Technology Limited (Robocore), a member of the Hong Kong Science and Technology Parks Corporation (HKSTP) Partner Programme, announced that it has recently completed its Series D funding
Alembic Pharmaceuticals Limited announced that the US Food and Drug Administration (USFDA) gave its final approval to their Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.
Natureoroma, based in Ramanagaram in the south of Bengaluru, has made Squacare, a gel for the mouth, made to help folks with oral submucous fibrosis (OSMF).
Accord BioPharma, Inc., the U.S. arm of Intas Pharmaceuticals, Ltd., has rolled out Imuldosa (ustekinumab-srlf), a match to Stelara (ustekinumab). Sold in ready-to-use syringes and vials, Imuldosa hits the market with the lowest cost
W Health Ventures has strengthened its leadership team with the addition of four seasoned industry leaders. Ashish Singh, Dr. Prakash Patel, and Ajay Sondhi join as Operating Partners, while Mahadevan “Mahad” Narayanamoni comes on board...
Merck a global leader in science and technology is partnered with company builder mantro GmbH (Munich, Germany) to accelerate the establishment of EdiMembre, a Deep-Tech spin-out from Massachusetts, U.S.A., that is poised to disrupt the
.jpeg){kind=spacer}
AN2 Therapeutics, a company working on new drug tech, shared that it has finished the first round of doses in a test of its new drug, AN2-502998.
Two intravenous (IV) doses of the antibiotic dalbavancin spaced seven days apart are just as effective at treating complicated Staphylococcus aureus bloodstream infections as daily IV doses of conventional antibiotics given over a period of four to
, CDSCO.jpg)